Research

Hormonal

Low baseline triglyceride levels (<1.7 mmol/L) predict a more sustained and significant weight loss and glycemic response to gastric contractility modulation (GCM) therapy.

If considering GCM therapy, checking baseline triglycerides may help predict success. Patients with lower triglycerides are more likely to experience sustained weight loss and better glycemic control from the device.

ModerateQualifiesLOW confidence
A subgroup analysis showed that patients with a triglyceride level of <1.7 mmol/L had a tendency toward a lower HbA1c level... In the low TG group, weight changes were similar to those in the INS group... with a significant between-group difference in favor of the GCM group.
Simon Kin‐Hung Wong et al. · Diabetes Technology & Therapeutics · 2015

Why this rating

Subgroup analysis of a small pilot study; p-values for subgroup differences are often underpowered.

Source

A Pilot Study to Compare Meal-Triggered Gastric Electrical Stimulation and Insulin Treatment in Chinese Obese Type 2 Diabetes

Simon Kin‐Hung Wong et al. · Diabetes Technology & Therapeutics · 2015

DOI 10.1089/dia.2014.0234

case_control · n=16Cited 6×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →